TRAW icon

Traws Pharma

17 hedge funds and large institutions have $5.92M invested in Traws Pharma in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
6
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$2.23M 2,664,934 +2,200,000 +473%
TCP
2
Tyndall Capital Partners
New York
$1.75M 2,097,022 +1,100,000 +110%
AC
3
Armistice Capital
New York
$1.13M 1,347,500 +1,347,500 New
SM
4
Sabby Management
Florida
$334K 399,580 -161,583 -29%
Vanguard Group
5
Vanguard Group
Pennsylvania
$287K 343,701 +186,300 +118%
Renaissance Technologies
6
Renaissance Technologies
New York
$123K 147,400 +38,200 +35%
PAM
7
Panagora Asset Management
Massachusetts
$33K 39,930 +4,900 +14%
Northern Trust
8
Northern Trust
Illinois
$16K 19,348 +19,348 New
Millennium Management
9
Millennium Management
New York
$12K 14,275 +14,275 New
Morgan Stanley
10
Morgan Stanley
New York
$8K 10,088 +10,088 New
UBS Group
11
UBS Group
Switzerland
$2K 2,036 +2,036 New
HFM
12
Hartford Financial Management
Connecticut
$1K 1,252
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K 1,020 +1,000 +5,000%
VF
14
Virtu Financial
New York
-12,839 Closed
Citadel Advisors
15
Citadel Advisors
Florida
-11,350 Closed
Macquarie Group
16
Macquarie Group
Australia
-5,108 Closed
CA
17
Calton & Associates
Florida
-250 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$0 31
Citigroup
19
Citigroup
New York
$0 100
BlackRock
20
BlackRock
New York
$0 652
Barclays
21
Barclays
United Kingdom
$0 60 +60 New